Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Clinical trial NCT00109772 · TERMINATED
Trial details
- NCT number
- NCT00109772
- Sponsor
- Celgene Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2008-04-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.